Billions for biotech: Oberland boosts biotech fund-raising past the $5B mark in a matter of weeks

The raise for Oberland Capital Healthcare Solutions Fund and affiliated funds (#3) weighed in at $1.05 billion, which was oversubscribed — a common sight over the last couple of months.

The pandemic has done nothing to slow the rollout of new funds.